tradingkey.logo
tradingkey.logo
Pesquisar

MiMedx Group Inc

MDXG
Adicionar à lista de desejos
3.930USD
+0.120+3.15%
Fechamento 06/26, 16:00ETCotações atrasadas em 15 min
582.01MValor de mercado
18.91P/L TTM

Mais detalhes de MiMedx Group Inc Empresa

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

Informações de MiMedx Group Inc

Código da empresaMDXG
Nome da EmpresaMiMedx Group Inc
Data de listagemAug 20, 2007
CEOCapper (Joseph H)
Número de funcionários837
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 20
Endereço1775 W Oak Commons Court, Ne
CidadeMARIETTA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal30062
Telefone17706519100
Sitehttps://mimedx.com/
Código da empresaMDXG
Data de listagemAug 20, 2007
CEOCapper (Joseph H)

Executivos da empresa MiMedx Group Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%

Perguntas frequentes

Quem são os cinco principais acionistas de MiMedx Group Inc?

Os cinco principais acionistas de MiMedx Group Inc são: Mr. Joseph H. (Joe) Capper

Quantas instituições possuem ações da MiMedx Group Inc (MDXG)?

Em 2026Q1, 462 instituições possuíam ações da MiMedx Group Inc, com valor de mercado aproximado de 116.77M, representando 78.40% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 6172968.00.

Qual é a maior fonte de receita da MiMedx Group Inc?

Em 2026Q1, o segmento de negócios Advanced Wound Care gerou a maior receita para MiMedx Group Inc, totalizando 276.33M e representando 66.01% da receita total.
KeyAI